Fml Forte Suspension/ Drops
Product Images NDC 11980-228

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fml Forte (NDC 11980-228). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Allergan, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fml Forte 01

Chemical structure of fluorometholone shown as a labeled molecular diagram. The graphic depicts the steroid backbone with annotated substituents including hydroxyl, methyl, fluoro, and ketone groups, consistent with the active ingredient fluorometholone.*

FDA Label Image

Fml Forte 02

FML FORTE 0.25% (fluorometholone ophthalmic suspension, USP) sterile 5 mL bottle label by Allergan, Inc. The label indicates prescription use with active ingredient fluorometholone 0.25% and instructs to shake well before use. Storage instructions include keeping at 2-25°C, protecting from freezing, and storing upright, with the bottle filled to half capacity. The label includes ingredients, lot, and expiry placeholders, as well as barcodes and manufacturer information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.